ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract 5194: Development of a cytotoxic fusion protein targeting VEGF receptors with improved cytotoxicity, stability and pharmacokinetics
Mapping Intimacies
◽
10.1158/1538-7445.am2020-5194
◽
2020
◽
Author(s):
Khalid A. Mohamedali
◽
Lawrence H. Cheung
◽
Ana A. Alvarez-Cienfuegos
◽
Michael G. Rosenblum
Keyword(s):
Fusion Protein
◽
Protein Targeting
◽
Vegf Receptors
Download Full-text
Related Documents
Cited By
References
Construction, expression and characterization of a dual cancer-specific fusion protein targeting carcinoembryonic antigen in intestinal carcinomas
Protein Expression and Purification
◽
10.1016/j.pep.2009.08.007
◽
2010
◽
Vol 69
(1)
◽
pp. 120-125
◽
Cited By ~ 6
Author(s):
Liu Yan
◽
Meng Xiangwei
◽
Li Xiao
◽
Gao Peng
◽
Li Chang
◽
...
Keyword(s):
Fusion Protein
◽
Carcinoembryonic Antigen
◽
Protein Targeting
Download Full-text
Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1
Toxicology in Vitro
◽
10.1016/j.tiv.2012.10.006
◽
2013
◽
Vol 27
(1)
◽
pp. 220-231
◽
Cited By ~ 22
Author(s):
Tracy R. Daniels-Wells
◽
Gustavo Helguera
◽
José A. Rodríguez
◽
Lai Sum Leoh
◽
Michael A. Erb
◽
...
Keyword(s):
Cell Death
◽
Fusion Protein
◽
Cancer Cells
◽
Transferrin Receptor
◽
Protein Targeting
◽
Transferrin Receptor 1
◽
Antibody Fusion Protein
Download Full-text
Abstract 1578: MTBhsp70 fusion protein targeting mesothelin augments tumor specific T cell responses and prolongs survival in a murine model of ovarian cancer
10.1158/1538-7445.am2012-1578
◽
2012
◽
Author(s):
Jianping Yuan
◽
Pierre Leblanc
◽
Satoshi Kashiwagi
◽
Jean Nezivar
◽
Elda Righi
◽
...
Keyword(s):
Ovarian Cancer
◽
T Cell
◽
Fusion Protein
◽
Murine Model
◽
Protein Targeting
◽
T Cell Responses
◽
Cell Responses
Download Full-text
Abstract CT075: Phase I evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus (HPV)-associated malignancies
10.1158/1538-7445.sabcs18-ct075
◽
2019
◽
Author(s):
Julius Strauss
◽
Margaret E. Gatti-Mays
◽
Byoung Cho
◽
Sébastien Salas
◽
Edward McClay
◽
...
Keyword(s):
Human Papillomavirus
◽
Fusion Protein
◽
Phase I
◽
Protein Targeting
◽
Bifunctional Fusion Protein
Download Full-text
Updated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer
Annals of Oncology
◽
10.1093/annonc/mdy282.045
◽
2018
◽
Vol 29
◽
pp. viii222-viii223
◽
Cited By ~ 5
Author(s):
Y.-J. Bang
◽
T. Doi
◽
S. Kondo
◽
H.C. Chung
◽
K. Muro
◽
...
Keyword(s):
Gastric Cancer
◽
Fusion Protein
◽
Phase I
◽
Phase I Trial
◽
Protein Targeting
◽
Bifunctional Fusion Protein
Download Full-text
Results from a second-line (2L) NSCLC cohort treated with M7824 (MSB0011359C), a bifunctional fusion protein targeting TGF-β and PD-L1.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.9017
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 9017-9017
◽
Cited By ~ 6
Author(s):
Luis G. Paz-Ares
◽
Tae Min Kim
◽
David Vicente Baz
◽
Enriqueta Felip
◽
Dae Ho Lee
◽
...
Keyword(s):
Fusion Protein
◽
Protein Targeting
◽
Second Line
◽
Bifunctional Fusion Protein
Download Full-text
Selection of the recommended phase 2 dose (RP2D) for M7824 (MSB0011359C), a bifunctional fusion protein targeting TGF-β and PD-L1.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.2566
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 2566-2566
◽
Cited By ~ 4
Author(s):
Yulia Vugmeyster
◽
Justin Wilkins
◽
Eleanor Harrison-Moench
◽
Wanping Geng
◽
Andre Koenig
◽
...
Keyword(s):
Fusion Protein
◽
Protein Targeting
◽
Phase 2
◽
Bifunctional Fusion Protein
◽
Selection Of
Download Full-text
P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy
Retrovirology
◽
10.1186/1742-4690-6-s3-p298
◽
2009
◽
Vol 6
(S3)
◽
Author(s):
S Culina
◽
G Zurawsky
◽
A Flamar
◽
P Brochard
◽
B Delache
◽
...
Keyword(s):
Fusion Protein
◽
Langerhans Cells
◽
Protein Targeting
◽
Hiv Vaccine
◽
Vaccine Strategy
◽
Anti Hiv
Download Full-text
957O Long-term follow-up of patients (pts) with human papillomavirus (HPV)–associated malignancies treated with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1
Annals of Oncology
◽
10.1016/j.annonc.2021.08.1342
◽
2021
◽
Vol 32
◽
pp. S829
Author(s):
J. Strauss
◽
M. Gatti-Mays
◽
B.C. Cho
◽
A. Hill
◽
S. Salas
◽
...
Keyword(s):
Human Papillomavirus
◽
Fusion Protein
◽
Protein Targeting
◽
Long Term Follow Up
◽
Bifunctional Fusion Protein
Download Full-text
776P SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, for pretreated advanced cervical cancer: Data from a clinical expansion cohort of a phase I study
Annals of Oncology
◽
10.1016/j.annonc.2021.08.1218
◽
2021
◽
Vol 32
◽
pp. S753
Author(s):
J. Feng
◽
J. Wang
◽
D. Tang
◽
Q. Zhou
◽
J. Peng
◽
...
Keyword(s):
Cervical Cancer
◽
Fusion Protein
◽
Phase I
◽
Phase I Study
◽
Protein Targeting
◽
Advanced Cervical Cancer
◽
Cancer Data
◽
Bifunctional Fusion Protein
◽
Expansion Cohort
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close